New funding will be used to support Jupiter Endovascular in its upcoming pivotal trial for Pulmonary Embolism. It will also … continue reading “Jupiter Endovascular Funding Means Green Light for Pulmonary Embolism Pivotal Trial”
Clinical/Educational
Insomnia Neurostimulation Tech on Show in China
A pioneering non-invasive neurostimulation technology for chronic insomnia will be showcased on the ABHI UK Pavilion at China’s CMEF 2024, … continue reading “Insomnia Neurostimulation Tech on Show in China”
Emboliner ® IDE Study 100 Patient Milestone
The Emboliner “Protect the Head to Head” investigational device exemption (IDE) clinical trial has seen its one hundredth patient enrolled. … continue reading “Emboliner ® IDE Study 100 Patient Milestone”
VARIPULSE™ Pulse Field Ablation (PFA) Platform Gains CE Mark
Biosense Webster, Inc., has announced European CE mark approval of the VARIPULSE™ Platform. The approval covers the treatment of symptomatic drug refractory … continue reading “VARIPULSE™ Pulse Field Ablation (PFA) Platform Gains CE Mark”
Medacs Expands Operation in Dubai to Help Grow Middle East Health Workforce
As Arab Health approaches, leading global staffing group Medacs announces it is expanding its Middle East operations to address health … continue reading “Medacs Expands Operation in Dubai to Help Grow Middle East Health Workforce”
Surgical Instrument Reuse and Repair Education for Healthcare Professionals
Surgical instrument reuse and repair is potentially important in the decarbonising of medical device use. With a shifting focus on … continue reading “Surgical Instrument Reuse and Repair Education for Healthcare Professionals”
Alzheimer’s Cognito Sensory Stimulation Study Promise
Cognito Therapeutics has announced publication of MRI imaging data from its Phase 2 OVERTURE study in the Journal of Alzheimer’s Disease … continue reading “Alzheimer’s Cognito Sensory Stimulation Study Promise”
Hemodialysis Access Promise from Polymer Implant
Netherlands and US-based medtech company Xeltis tells us about its first-in-human (FIH) vascular conduit trial for hemodialysis access. Vascular surgeon … continue reading “Hemodialysis Access Promise from Polymer Implant”
Severe Sleep Apnea “Game-Changing” FDA Clearance
Vivos Therapeutics, Inc. says its removable CARE (Complete Airway Repositioning and/or Expansion) oral appliance has been granted U. S. FDA … continue reading “Severe Sleep Apnea “Game-Changing” FDA Clearance”
Spyral ™ Gains FDA Approval
Medtronic plc says the US FDA has approved the Symplicity Spyral ™ renal denervation (RDN) system as an adjunct to … continue reading “Spyral ™ Gains FDA Approval”
SELUTION SLR Coronary Sirolimus DEB Study: First US Patient Enrolled
The first US patient has been enrolled at Medstar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™ to … continue reading “SELUTION SLR Coronary Sirolimus DEB Study: First US Patient Enrolled”
Breast Cancer EU Study Patients for CairnSurgical BCLTM System
CairnSurgical, Inc., an innovator striving to make breast cancer surgery more precise, has announced that the first patients have been … continue reading “Breast Cancer EU Study Patients for CairnSurgical BCLTM System”
Venous Leg Ulcers; Economics and MedTech’s Answers
Technological advancements such as Sky Medical Technology‘s wearable geko™ device mark a new era in the treatment of Venous Leg … continue reading “Venous Leg Ulcers; Economics and MedTech’s Answers”
First Patient Receives Fully Implanted Acclaim® Cochlear Implant in Envoy Medical Early Feasibility Study
Envoy Medical® Corporation tells us the first patient has been enrolled and implanted in the Acclaim® Cochlear Implant early feasibility … continue reading “First Patient Receives Fully Implanted Acclaim® Cochlear Implant in Envoy Medical Early Feasibility Study”
First-in-Human Trial will Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation
Swiss company Argá Medtech has begun enrollment in a First-in-Human Clinical Trial of its CSE Ablation System in the treatment … continue reading “First-in-Human Trial will Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation”
New Data Says Patient Experience Worsening
New data to be presented at this year’s NHS ConfedExpo (15 – 16 June 2022) reveals patient experience over the … continue reading “New Data Says Patient Experience Worsening”